Overview Retatrutide 30 is a research-grade triple-agonist peptide used to study signaling pathways associated with GLP-1, GIP, and glucagon receptors.
Research Focus Researchers use Retatrutide 30 to investigate multi-receptor signaling integration, incretin-pathway modeling, and metabolic signaling cascades.
Mechanism of Interest Its multi-agonist binding profile allows examination of receptor crosstalk and intracellular signaling events in metabolic models.
Compliance Notice For research only. Not for human consumption.

